Trials / Unknown
UnknownNCT01317173
Factors Related to the Progression of Chronic Kidney Disease
The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Ankara Education and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.
Conditions
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2011-05-01
- Completion
- 2011-06-01
- First posted
- 2011-03-17
- Last updated
- 2011-03-17
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01317173. Inclusion in this directory is not an endorsement.